Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal

Li-ying Han1, Ming-zhu Ye, Ya-ping Li

  • 1Department of Obstetrics and Gynecology, Second Hospital, Jilin University, Changchun, Jilin, China.

Chinese Medical Journal
|August 15, 2008
PubMed
Abstract

Insights

This study successfully transferred the human multidrug resistance (mdr1) gene into placenta mesenchymal stem cells (P-MSCs) using a retrovirus vector. Transfected P-MSCs exhibited significant multidrug resistance, offering a potential new strategy for chemoprotection.

Area of Science:

  • Stem cell biology
  • Gene therapy
  • Cancer research

Background:

  • Gynecologic cancers often respond to chemotherapy, but myelosuppression is a common dose-limiting toxicity.
  • The human multidrug resistance (mdr1) gene confers resistance to various chemotherapeutic agents.
  • Placenta-derived mesenchymal stem cells (P-MSCs) are a potential candidate for therapeutic applications.

Purpose of the Study:

  • To investigate the feasibility of transducing the mdr1 gene into human P-MSCs using a retroviral vector.
  • To evaluate the expression and drug resistance conferred by the mdr1 gene in P-MSCs.

Main Methods:

  • Human P-MSCs were isolated, characterized for immunophenotype and differentiation potential, and transduced with a retroviral vector containing the mdr1 and green fluorescent protein (GFP) genes.
  • GFP expression was used to indirectly assess mdr1 gene integration and expression.
  • Fluorescence-activated cell sorting (FACS) and in vitro assays were employed to evaluate P-glycoprotein (P-gp) function and multidrug resistance in transfected cells.

Main Results:

  • Transduced P-MSCs expressed stem cell markers and retained differentiation potential.
  • MDR1 gene transfection significantly increased P-gp expression in P-MSCs from 0.4% to 28.1% (P < 0.01).
  • Functional assays confirmed P-gp's ability to efflux daunomycin and demonstrated multidrug resistance in transfected P-MSCs.

Conclusions:

  • Retroviral-mediated transfer and expression of the human mdr1 gene successfully conferred multidrug resistance to P-MSCs.
  • This approach may offer a novel strategy for chemoprotection against chemotherapy-induced toxicities.

Related Concept Videos